Vigilare Wealth Management’s ImmunityBio IBRX Stock Holding History

Vigilare Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$148K	Buy	16,890 +70	+0.4%	+$530	0.05%	123
2026 Q1	$129K	Buy	16,820 +6,120	+57%	+$41.9K	0.04%	109
2025 Q4	$21.2K	Sell	10,700 -900	-8%	-$2.04K	0.01%	116
2025 Q3	$28.5K	Sell	11,600 -100	-0.9%	-$258	0.01%	120
2025 Q2	$30.9K	Buy	+11,700	New	+$31.5K	0.01%	119

Other funds holding IBRX

SSWM

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MWM

MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return

DKCM

Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CFO

Collective Family Office York, Pennsylvania $489M AUM 21.64% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

CIC

Cutler Investment Counsel Jacksonville, Oregon $1.06B AUM 20.29% 1-Year Est. Return

Vigilare Wealth Management's IBRX Position: Q2 2026 in Review

Vigilare Wealth Management increased its ImmunityBio (IBRX) stake by 0.42% in Q2 2026, buying an estimated $530 and bringing the position to 16,890 shares worth $148K. The position accounts for 0.05% of the portfolio, ranked #123.

Vigilare Wealth Management first reported a position in IBRX in Q2 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Vigilare Wealth Management held 16,890 shares of ImmunityBio worth $148K as of Q2 2026.
Vigilare Wealth Management bought 70 ImmunityBio shares in Q2 2026, an estimated $530.
ImmunityBio made up 0.05% of Vigilare Wealth Management's portfolio in Q2 2026, its #123 holding.
Vigilare Wealth Management first reported a position in ImmunityBio in Q2 2025 and has held it in 5 quarters since.
54 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Vigilare Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.